Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| EZRI | P15311 | Ezrin (Cytovillin) (Villin-2) (p81) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 2 | 0.50 | ||||
| FZD4 | Q9ULV1 | Frizzled-4 (Fz-4) (hFz4) (FzE4) (CD antigen CD344) | CD markersDisease related genesG-protein coupled receptors | 7 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.50 | |||
| GABR1 | Q9UBS5 | Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) | FDA approved drug targetsG-protein coupled receptorsPlasma proteins | 7 | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 2 | 0.50 | |||
| GAS2 | O43903 | Growth arrest-specific protein 2 (GAS-2) | Predicted intracellular proteins | Fusion and delivery mediation | 2 | 0.50 | ||||
| GLT12 | Q8IXK2 | Polypeptide N-acetylgalactosaminyltransferase 12 (EC 2.4.1.41) (Polypeptide GalNAc transferase 12) (GalNAc-T12) (pp-GaNTase 12) (Protein-UDP acetylgalactosaminyltransferase 12) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12) | Disease related genesEnzymesHuman disease related genes | 1 | Clinical-translation mediationMetabolism mediation | 2 | 0.50 | |||
| GTR1 | P11166 | Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter) | Cancer-related genesDisease related genesHuman disease related genes | 12 | Skin disease | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 2 | 0.50 | ||
| GUC1A | P43080 | Guanylyl cyclase-activating protein 1 (GCAP 1) (Guanylate cyclase activator 1A) | Disease related genesHuman disease related genesPredicted intracellular proteins | Receptor-signaling mediation | 2 | 0.50 | ||||
| ITA8 | P53708 | Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain] | Disease related genesHuman disease related genesPlasma proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 2 | 0.50 | |||
| ITAX | P20702 | Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.50 | |||
| KC1D | P48730 | Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) | Disease related genesEnzymesHuman disease related genes | Mature B-cell leukaemiaPancreatic cancer | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 2 | 0.50 | |||
| KISSR | Q969F8 | KiSS-1 receptor (KiSS-1R) (G-protein coupled receptor 54) (G-protein coupled receptor OT7T175) (hOT7T175) (Hypogonadotropin-1) (Kisspeptins receptor) (Metastin receptor) | Disease related genesG-protein coupled receptorsHuman disease related genes | 7 | Allergic/hypersensitivity disorderProstate cancer | Clinical-translation mediationReceptor-signaling mediation | 2 | 0.50 | ||
| L1CAM | P32004 | Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171) | CD markersDisease related genesHuman disease related genes | 1 | Adrenal cancerBrain cancer | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 2 | 0.50 | ||
| LAMP2 | P13473 | Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b) | CD markersDisease related genesHuman disease related genes | 1 | Inborn carbohydrate metabolism error | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.50 | ||
| LIGO1 | Q96FE5 | Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A) | Disease related genesHuman disease related genesPotential drug targets | 1 | Multiple sclerosis | Clinical-translation mediationReceptor-signaling mediation | 2 | 0.50 | ||
| LPAR6 | P43657 | Lysophosphatidic acid receptor 6 (LPA receptor 6) (LPA-6) (Oleoyl-L-alpha-lysophosphatidic acid receptor) (P2Y purinoceptor 5) (P2Y5) (Purinergic receptor 5) (RB intron encoded G-protein coupled receptor) | Disease related genesG-protein coupled receptorsHuman disease related genes | 7 | Receptor-signaling mediation | 2 | 0.50 | |||
| LRP12 | Q9Y561 | Low-density lipoprotein receptor-related protein 12 (LDLR-related protein 12) (LRP-12) (Suppressor of tumorigenicity 7 protein) | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Metabolism mediation | 2 | 0.50 | |||
| MADD | Q8WXG6 | MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (Rab3GEP) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 2 | 0.50 | ||||
| MLIP | Q5VWP3 | Muscular LMNA-interacting protein (Cardiac Isl1-interacting protein) (CIP) (Muscular-enriched A-type laminin-interacting protein) | Disease related genesPredicted intracellular proteins | Other mediation | 2 | 0.50 | ||||
| MOES | P26038 | Moesin (Membrane-organizing extension spike protein) | Cancer-related genesDisease related genesHuman disease related genes | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.50 | ||||
| NF1 | P21359 | Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated] | Cancer-related genesDisease related genesHuman disease related genes | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.50 | ||||
| NLS1 | Q8NA29 | Sodium-dependent lysophosphatidylcholine symporter 1 (NLS1) (Sodium-dependent LPC symporter 1) (Major facilitator superfamily domain-containing protein 2A) (HsMFSD2A) (MFSD2a) | Disease related genesHuman disease related genesPotential drug targets | 12 | Fusion and delivery mediationMetabolism mediation | 2 | 0.50 | |||
| OPRK | P41145 | Kappa-type opioid receptor (K-OR-1) (KOR-1) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Bipolar disorderChronic painCoronary vasospastic disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.50 | ||
| PANX1 | Q96RD7 | Pannexin-1 (PANX1) [Cleaved into: Caspase-activated pannexin-1 (Caspase-activated PANX1)] | Disease related genesHuman disease related genesPotential drug targets | 4 | Fusion and delivery mediationImmune mediation | 2 | 0.50 | |||
| PARD3 | Q8TEW0 | Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha) | Disease related genesPlasma proteinsPredicted intracellular proteins | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 2 | 0.50 | ||||
| PIGN | O95427 | GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (GPI-ethanolamine transferase I) (GPI-ETI) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N) | Disease related genesHuman disease related genesMetabolic proteins | 15 | Metabolism mediation | 2 | 0.50 |